Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.
Nicaise Roland P, Grootenboer Mignot S, Bruns A, Hurtado M, Palazzo E, Hayem G, Dieudé P, Meyer O, Chollet Martin S. Nicaise Roland P, et al. Among authors: dieude p. Arthritis Res Ther. 2008;10(6):R142. doi: 10.1186/ar2570. Epub 2008 Dec 10. Arthritis Res Ther. 2008. PMID: 19077182 Free PMC article. Clinical Trial.
Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O. Bruns A, et al. Among authors: dieude p. Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8. Joint Bone Spine. 2009. PMID: 19208451
Intramedullary tuberculoma during infliximab therapy.
Ottaviani S, Meyer O, Dieudé P. Ottaviani S, et al. Among authors: dieude p. Rheumatology (Oxford). 2010 Jan;49(1):42. doi: 10.1093/rheumatology/kep267. Epub 2009 Sep 4. Rheumatology (Oxford). 2010. PMID: 19734294 No abstract available.
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients.
de Bandt M, Fautrel B, Maillefert JF, Berthelot JM, Combe B, Flipo RM, Lioté F, Meyer O, Saraux A, Wendling D, Le Loët X, Guillemin F; STPR group of the French Society of Rheumatology. de Bandt M, et al. Arthritis Res Ther. 2009;11(5):R157. doi: 10.1186/ar2836. Epub 2009 Oct 23. Arthritis Res Ther. 2009. PMID: 19849865 Free PMC article.
Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
Meyer O, De Chaisemartin L, Nicaise-Roland P, Cabane J, Tubach F, Dieude P, Hayem G, Palazzo E, Chollet-Martin S, Kahan A, Allanore Y. Meyer O, et al. Among authors: dieude p. J Rheumatol. 2010 Jan;37(1):125-30. doi: 10.3899/jrheum.090677. Epub 2009 Nov 16. J Rheumatol. 2010. PMID: 19918031
261 results